Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CHRM1CHRM2CHRM3CHRM4ESR1ESR2GABRA1GABRB1GABRG2GBA1HRH1HTR1DHTR2AOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.91 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.43 |
| ▸ | PDE4A | P27815 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.38 |
| ▸ | F2 | P00734 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cadaverine Tartrate SCHEMBL29382062 | 0.95 | TSHR (1.00) | TSHRTP53CYP2C9PDE4ALMNA | |
| Tartaric Acid SCHEMBL29430365 | 0.95 | TSHR (1.00) | TSHRTP53CYP2C9PDE4ALMNA | |
| Cadaverine Tartrate SCHEMBL1062721 | 0.95 | TSHR (1.00) | TSHRTP53CYP2C9PDE4ALMNA | |
| Cadaverine Tartrate SCHEMBL116846 | 0.95 | TSHR (1.00) | TSHRTP53CYP2C9PDE4ALMNA | |
| Cadaverine Tartrate SCHEMBL22768 | 0.95 | TSHR (1.00) | TSHRTP53CYP2C9PDE4ALMNA | |
| Cadaverine Tartrate SCHEMBL31427568 | 0.95 | TSHR (1.00) | TSHRTP53CYP2C9PDE4ALMNA | |
| Cadaverine Tartrate SCHEMBL848 | 0.95 | TSHR (1.00) | TSHRTP53CYP2C9PDE4ALMNA | |
| Tartaric Acid SCHEMBL5762 | 0.95 | TSHR (1.00) | TSHRTP53CYP2C9PDE4ALMNA | |
| Cadaverine Tartrate SCHEMBL1431070 | 0.95 | TSHR (1.00) | TSHRTP53CYP2C9PDE4ALMNA | |
| Cadaverine Tartrate SCHEMBL30689288 | 0.95 | TSHR (1.00) | TSHRTP53CYP2C9PDE4ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 219 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250345482-A1 | 3D PRINTED GALLIUM SCAFFOLD | NORTHEAST OHIO MEDICAL UNIV (US) | 2025-11-13 | — | — | US | claimed |
| WO-2024137849-A1 | GALLIUM-LOADED HYDROGELS FOR BONE TREATMENT | NORTHEAST OHIO MEDICAL UNIVERSITY (US) | 2024-06-27 | — | — | WO | claimed |
| US-11213530-B2 | Gallium in the treatment of coronavirus disease | BERNSTEIN LAWRENCE RICHARD (US) | 2022-01-04 | — | — | US | claimed |
| WO-2021258086-A2 | GALLIUM IN THE TREATENT OF CORONAVIRUS DISEASE | BERNSTEIN LAWRENCE (US) | 2021-12-23 | — | — | WO | claimed |
| US-20210275544-A1 | Gallium in the treatment of coronavirus disease | BERNSTEIN LAWRENCE RICHARD (US) | 2021-09-09 | — | — | US | claimed |
| US-10632148-B2 | Growth control of oral and superficial organisms using gallium compounds | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2020-04-28 | — | — | US | claimed |
| US-20190255100-A1 | TREATMENT OF CARDIOVASCULAR DISEASE BY USING GALLIUM COMPOUNDS TO BIND CALCIFIED LESIONS | LIPIDRISK, LLC | 2019-08-22 | — | — | US | claimed |
| US-20190175644-A1 | METHODS FOR PREVENTING OR TREATING INFECTIOUS DISEASES CAUSED BY EXTRACELLULAR MICROORGANISMS, INCLUDING ANTIMICROBIAL-RESISTANT STRAINS THEREOF, USING GALLIUM COMPOUNDS | CAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2019-06-13 | — | — | US | claimed |
| CN-104473962-B | Controlled using the growth of the oral area and surface microorganism of gallium compound | 西奈山医学院 | 2018-05-01 | — | — | CN | claimed |
| US-20180028564-A1 | METHODS FOR PREVENTING OR TREATING INFECTIOUS DISEASES CAUSED BY EXTRACELLULAR MICROORGANISMS, INCLUDING ANTIMICROBIAL-RESISTANT STRAINS THEREOF, USING GALLIUM COMPOUNDS | CAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2018-02-01 | — | — | US | claimed |
| US-5556645-A | TISSUES TREATED WITH GALLIUM COMPOUND | NEW YORK SOCIETY FOR THE RELIEF OF THE RUPTURED AND CRIPPLED, MAINTAINING THE HOSPITAL FOR SPECIAL SURGERY | 1996-09-17 | — | — | US | claimed |
| EP-0463126-A4 | METHODS OF ENHANCING WOUND HEALING AND TISSUE REPAIR | — | 1993-03-24 | — | — | EP | claimed |
| US-5175006-A | Method of treating arthritis using gallium compounds | THE OHIO STATE UNIVERSITY (US) | 1992-12-29 | — | — | US | claimed |
| WO-1992004896-A1 | METHOD OF TREATING AUTO-IMMUNE DISEASES USING GALLIUM COMPOUNDS | THE OHIO STATE UNIVERSITY (US) | 1992-04-02 | — | — | WO | claimed |
| EP-0463126-A1 | METHODS OF ENHANCING WOUND HEALING AND TISSUE REPAIR | NEW YORK SOCIETY FOR THE RELIEF OF THE RUPTURED AND CRIPPLED MAINTAINING THE HOSPITAL FOR SPECIAL SURGERY (US) | 1992-01-02 | — | — | EP | claimed |
| WO-1991010437-A1 | METHODS OF ENHANCING WOUND HEALING AND TISSUE REPAIR | NEW YORK SOCIETY FOR THE RELIEF OF THE RUPTURED AND CRIPPLED, MAINTAINING THE HOSPITAL FOR SPECIAL SURGERY (US) | 1991-07-25 | — | — | WO | claimed |
| EP-0109564-B1 | THE USE OF GALLIUM SALTS FOR THE MANUFACTURE OF PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISORDERS OF CALCIUM HOMEOSTASIS | Sloan-Kettering Institute For Cancer Research (US) | 1988-04-27 | — | — | EP | claimed |
| US-4704277-A | GALLIUM COMPOUND TO INCREASE CALCIUM ACCRETION | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1987-11-03 | — | — | US | claimed |
| US-4529593-A | Use of gallium salts to treat disorders of calcium homeostasis | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1985-07-16 | — | — | US | claimed |
| US-4448763-A | RADIOACTIVE GALLIUM AND NON-RADIOACTIVE INDIUM | THE UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 1984-05-15 | — | — | US | claimed |